Previously, we and others have reported that inhibition of GSK3β activity attenuated proliferation and invasion of GBM cells and sensitized them to chemotherapeutic agents and radiation by modulating distinctive molecular pathways [19, 29]. The gene discussed is GSK3B; the disease is glioblastoma.